🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Announcing Tim Hunt, CEO Alliance for Regenerative Medicine (ARM), will be delivering a state-of-the-industry briefing on the #genetherapy space at the #AAV Innovation Summit on November 6th in Cambridge, MA. See the full agenda: hubs.li/Q02TS9xK0

Calling all Boston-based #genetherapy professionals. Join the #AAV Innovation Summit 2024 to explore cutting-edge advancements in optimizing genome integrity through #AI & vector design. Speakers: Alliance for Regenerative Medicine (ARM) UMass Chan Medical School PacBio Resilience Solid Biosciences hubs.li/Q02Vb54j0

Species-specific codon optimization has been valuable for decades. In this case study, we compare our #AI/ML model to an open-source tool for enzyme optimization, achieving a 20% increase in mRNA transcript levels and enzyme activity. hubs.li/Q02RnJLY0 #genetherapy

Check out the #AAV Resource Hub, your one-stop shop for all things AAV, brought to you by Form Bio & PacBio. Featuring an AAV data dictionary, open-source tools, best practices, standards, & more—driven by a newly formed AAV Working Group. hubs.li/Q02RnQCf0 #genetherapy

🚀 Exciting news: the Long-read AAV Analysis (LAAVA) pipeline has reached version 3.0! 🎉 This update pays special attention to "snapback" vector genomes. Now available on #Github: hubs.li/Q02WnXLT0 #genetherapy

🚨 Last chance to register! 🚨 Don’t miss the #AAV #Innovation Summit 2024—a unique opportunity to dive into the latest advancements in optimizing genome integrity through #AI and vector design. hubs.li/Q02WtHWh0

🚀 Advances in #AAV Manufacturing for #GeneTherapy! Our blog dives into the nuances of the AAV manufacturing process and the innovative solutions helping to optimize production, reduce impurities, & ensure therapeutic efficacy. Read more! hubs.li/Q02YhYrM0

🚀 The promise of #genetherapy is undeniable—but development challenges can hold programs back. Form Bio leverages #AI-driven #insilico workflows to de-risk #AAV vector design, reducing costly iteration cycles. Watch a short video on how it works: hubs.li/Q02YYhBK0

🚀 CASE STUDY: AI/ML Optimizes AAV CDS, Reducing Genome Truncations Reducing partial genomes is a critical objective in #AAV #genetherapy development to ensure the production of functional, high-quality therapeutic vectors. Check out the case study: hubs.li/Q02Y_8130

🚀 CASE STUDY: AI/ML Codon Optimization Improves Enzymatic Activity by 20%. Check out the full scientific case study: hubs.li/Q02Y_cRm0 #GeneTherapy #AI #AAV

CASE STUDY: Reducing Immunogenicity Risk with AI/ML Check out how #AI/ML models can optimize the CDS of a housekeeping gene, leading to the reduction in %CPG peaks without altering %GC content. hubs.li/Q02Zzh1c0 #genetherapy #AAV

🚀 CASE STUDY: #AI/ML Accelerates AAV Discovery Traditional #AAV vector development is a slow iterative process. Within days, using FORMsightAI we identified 4 optimized vector designs, achieving 91% full capsids. Learn more: hubs.li/Q02Zztyn0 #genetherapy

💡CASE STUDY: Boost #AAV Manufacturability with #AI/ML Partially filled AAV capsids are a challenge in #genetherapy. AI/ML offers a solution by simulating promoter performance, reducing risk of genome truncations during replication. Learn More: hubs.li/Q02ZzN__0

🌟Newly Announced Speakers for the #AAV Innovation Summit–Mar 20 NCBiotech #NCLifeSciences. Early bird registration ends Feb 28—register now & save $100! Networking reception to follow. 🔗hubs.li/Q038rrQv0 #genetherapy

🔥Spots are filling fast—this event is on track to sell out! 🔥Join us for a half-day summit on #AAV #innovation w/ experts from UNC-Chapel Hill, University of Massachusetts, AskBio Inc. (AskBio), Alliance for Regenerative Medicine (ARM), PacBio & more. hubs.li/Q039jsfQ0

Form Bio is proud to be the tech behind Colossal’s dire wolf project, advancing large-scale comparative #genomics to analyze ancient DNA alongside genomes of related species to unlock key phenotypic traits. Learn more: hubs.ly/Q03hjsgF0

The woolly mouse is what happens when visionary science meets cutting-edge #AI. At Form Bio, we’re not just powering de-extinction—we’re building tech that’s transforming #geneediting for human health. Learn more. hubs.li/Q03jCLD20

Form Bio is the tech turning visionary science into reality. From de-extinction to cutting-edge #CGT, our tools design #CRISPR guides at scale, detect off-target edits, & predict functional impact. Let’s talk how we can support your next breakthrough. hubs.li/Q03khCRt0

We’re heading to #ASGCT25! Pre-book a meeting with our team or stop by booth #1143 to learn how to improve #AAV #genetherapy development. Join us for in-booth activities featuring our partners Azenta, PacBio and Stanford University. hubs.li/Q03lkL8h0

🎉 Big congrats to Brandi Cantarel, PhD, VP of Bioinformatics at @FormBio, for being named one of Dallas Innovates’ Top 75 #AI Innovators in North Texas! 👏 She’s pioneering AI in #genomics to accelerate breakthroughs in human health. 🧬 Read more: hubs.li/Q03ltj0y0